Dexmedetomidine Regulates the PI3K/AKT Signaling Pathway to Improve Lipopolysaccharide-induced Colitis Colon Epithelial Cell Injury

DONG Jianglong; SONG Wanjun; SHAN Xin; TONG Yefeng

doi:10.3969/j.issn.1007-7146.2024.04.010

Acta Laser Biology Sinica, Volume. 33, Issue 4, 377(2024)

Dexmedetomidine Regulates the PI3K/AKT Signaling Pathway to Improve Lipopolysaccharide-induced Colitis Colon Epithelial Cell Injury

DONG Jianglong^1、*, SONG Wanjun¹, SHAN Xin¹, and TONG Yefeng²

Author Affiliations

¹The Third Hospital of Hebei Medical University Department of Anesthesia I, Shijiazhuang 050051, China

²The Third Hospital of Hebei Medical University Department of Anesthesia II, Shijiazhuang 050051, China

show less

Figures & Tables(0)

Tools

Get Citation

Copy Citation Text

DONG Jianglong, SONG Wanjun, SHAN Xin, TONG Yefeng. Dexmedetomidine Regulates the PI3K/AKT Signaling Pathway to Improve Lipopolysaccharide-induced Colitis Colon Epithelial Cell Injury[J]. Acta Laser Biology Sinica, 2024, 33(4): 377

Download Citation

EndNote(RIS)BibTex Plain Text

Set citation alerts for article

Save article for my favorites

Paper Information

Category:

Received: Oct. 23, 2023

Accepted: Dec. 20, 2024

Published Online: Dec. 20, 2024

The Author Email: Jianglong DONG (dong13131139331@163.com)

DOI:10.3969/j.issn.1007-7146.2024.04.010

Topics

laser devices and laser physics

Lasers and Laser Optics

Laser physics

laser manufacturing

Instrumentation, Measurement and Metrology